Literature DB >> 16182186

Vancomycin for multi-drug resistant Enterococcus faecium cholangiohepatitis in a cat.

Michelle A Pressel1, Leslie E Fox, Michael D Apley, Frank J Simutis.   

Abstract

A 12-year-old, neutered male domestic shorthair cat was evaluated with a life-long history of intermittent, predominantly small bowel diarrhea and a 3 day history of hematochezia. At presentation, the cat had increased liver enzyme activities and an inflammatory leukogram. Histopathology demonstrated inflammatory bowel disease (IBD), cholangiohepatitis and pancreatitis. The cholangiohepatitis was associated with a multi-drug resistant Enterococcus faecium. Gallbladder agenesis was also documented. Treatment with vancomycin was safely instituted for 10 days. Clinical signs resolved, however, cure of the bacterial cholangiohepatitis was not achieved. The risk of vancomycin resistant enterococci (VRE) in human and veterinary medicine is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182186     DOI: 10.1016/j.jfms.2005.01.001

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  3 in total

1.  Resident Cats in Small Animal Veterinary Hospitals Carry Multi-Drug Resistant Enterococci and are Likely Involved in Cross-Contamination of the Hospital Environment.

Authors:  Anuradha Ghosh; Kate Kukanich; Caitlin E Brown; Ludek Zurek
Journal:  Front Microbiol       Date:  2012-02-21       Impact factor: 5.640

2.  Parenterally administered vancomycin in 29 dogs and 7 cats (2003-2017).

Authors:  Ian M DeStefano; Annie S Wayne; Elizabeth A Rozanski; Jonathan M Babyak
Journal:  J Vet Intern Med       Date:  2018-11-30       Impact factor: 3.333

3.  Prevalence and Clinicopathological Features of Triaditis in a Prospective Case Series of Symptomatic and Asymptomatic Cats.

Authors:  F C Fragkou; K K Adamama-Moraitou; T Poutahidis; N N Prassinos; M Kritsepi-Konstantinou; P G Xenoulis; J M Steiner; J A Lidbury; J S Suchodolski; T S Rallis
Journal:  J Vet Intern Med       Date:  2016-06-14       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.